U.S. flag

An official website of the United States government, Department of Justice.

Pharmaceutical Crime Investigation and Prosecution Training Program

Award Information

Award #
Congressional District
Funding First Awarded
Total funding (to date)

Description of original award (Fiscal Year 2010, $1,000,000)

The National Initiatives: Addressing Substance Abuse program, administered by the Office of Justice Programs' (OJP) Bureau of Justice Assistance (BJA), aims to improve the functioning of the criminal justice system and provide assistance to victims of crime (other than compensation) by providing assistance to communities in responding to substance abuse-related crime. Throughout the criminal justice system, there are demonstrably higher rates of substance abuse among offenders than among the general population. OJP provides many programs and services that assist communities in planning, implementing, and enhancing criminal justice responses such as tools for law enforcement to address the substance abusing offender, drug courts, jail and prison treatment programs, and reentry programs. The FY 2010 National Initiatives: Addressing Substance Abuse solicitation focuses on two critical issue areas that law enforcement and others in the criminal justice system encounter daily: drug-endangered children and pharmaceutical crime.

The National District Attorneys Association (NDAA) will identify the most current and important issues in pharmaceutical crimes prosecution and assist in the increase of knowledge and skills of criminal justice practitioners in dealing with these issues. NDAA will create a curriculum and deliver the training at three regional conferences throughout the United States. Goals under this initiative are to: increase the knowledge of criminal justice practitioners relating to pharmaceutical crimes through curriculum development, revision, and training; increase the information relating to pharmaceutical crimes provided to BJA and the criminal justice community; and increase the abilities of several criminal justice agencies to solve problems and modify policies or practices relating to pharmaceutical crimes.


Date Created: September 20, 2010